Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for chronic insomnia in children aged 1 to 3 years
IRCT20180719040526N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Insomnia comparing Melatonin with Placebo (2 arms). Primary endpoints: sleep duration, sleep quality and 1 more. Started Jan 2018; status: completed.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on IRCT20180719040526N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180719040526N1.